Clinical Trial Update: Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 study evaluating a modified FOLFIRINOX regimen alternated with biweekly gemcitabine plus nab-paclitaxel in untreated metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• FOLFIRINOX
• Folinic acid (folinic acid)
• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)
• Nab-paclitaxel (paclitaxel protein-bound)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Lyudmyla Berim | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING